Cadila Pharmaceuticals Ltd
Next 500 2018
+ 3 More
+ 3 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#35(2018)#56(2017)#82(2016)#145(2015)
#35(2018)#56(2017)#82(2016)#145(2015)
Ranking Trend Fortune Next 500 India
Financial Data 2023
Revenue
3,757
(INR Cr)
Net Operating Income
3,676
(INR Cr)
Assets
3,744
(INR Cr)
Profit
-44
(INR Cr)
Net Worth
1,748
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 3757 15.2% | 3261 19.2% | 2735 29.1% | 2118 13.3% | 1870 13.1% | 1654 0.7% | 1642 -10.7% | 1839 19.6% | 1538 3.8% | 1482 35.4% | 1094 17.5% | 931 13.8% | 818 24.1% | 659 - |
| Net Operating Income (INR Cr) | 3676 14.01% | 3224 19.85% | 2690 0.00% | 2082 12.85% | 1845 9.69% | 1682 6.21% | 1584 8.06% | 1511 4.43% | 1447 4.93% | 1379 0.00% | 1085 18.16% | 918 17.45% | 782 20.65% | 648 0.00% |
| Profit (INR Cr) | -44 - | 189 -40.8% | 319 94.1% | 164 103.8% | 81 5.5% | 76 44.6% | 53 -82.5% | 302 221.3% | 94 -35.0% | 145 381.5% | 30 111.8% | 14 49.1% | 10 437.9% | 2 - |
| Assets (INR Cr) | 3744 37.7% | 2719 8.7% | 2501 87.9% | 1331 6.0% | 1256 4.8% | 1198 8.6% | 1104 -16.5% | 1322 40.3% | 942 -1.4% | 955 -2.2% | 977 15.9% | 843 8.1% | 780 18.5% | 658 - |
| Net Worth (INR Cr) | 1748 32.4% | 1321 1.8% | 1298 0.0% | 533 11.9% | 476 3.4% | 460 19.7% | 385 8.9% | 634 75.2% | 362 10.7% | 327 0.0% | 350 50.7% | 232 4.1% | 223 4.5% | 213 0.0% |
| Employee Cost (INR Cr) | 605 30.1% | 465 7.4% | 433 13.1% | 383 13.2% | 338 1.3% | 334 2.4% | 326 10.3% | 296 16.3% | 254 4.2% | 244 26.9% | 192 28.8% | 149 24.3% | 120 27.3% | 94 - |
| Interest Cost (INR Cr) | 100 | 66 | 67 | 76 | 70 | 62 | 69 | 56 | 53 | 70 | 64 | 61 | 44 | 42 |
| Cash & Bank Balance (INR Cr) | 197 | 142 | 110 | 41 | 27 | 19 | 26 | 313 | 41 | 85 | 34 | 17 | 20 | 27 |
| Total Debt (INR Cr) | 1452 | 921 | 1041 | 718 | 716 | 680 | 661 | 619 | 522 | 579 | 600 | 588 | 533 | 445 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | - | 5.8% | 11.7% | 7.8% | 4.3% | 4.6% | 3.2% | 16.4% | 6.1% | 9.8% | 2.8% | 1.5% | 1.2% | 0.3% |
| Profit As % Of Assets | - | 6.9% | 12.7% | 12.3% | 6.4% | 6.4% | 4.8% | 22.9% | 10.0% | 15.2% | 3.1% | 1.7% | 1.2% | 0.3% |
| Profit As % Of Networth | - | 14.3% | 24.6% | 30.8% | 16.9% | 16.6% | 13.7% | 47.7% | 26.0% | 44.3% | 8.6% | 6.1% | 4.3% | 0.8% |
| Interest Cost to EBITDA % | 67.2% | 13.0% | 11.9% | 23.8% | 31.0% | 31.8% | 37.5% | 39.3% | 33.7% | 42.3% | 56.5% | 64.4% | 58.5% | 100.7% |
| Debt to Equity Ratio | 0.83 | 0.70 | 0.80 | 1.35 | 1.50 | 1.48 | 1.72 | 0.98 | 1.44 | 1.77 | 1.72 | 2.53 | 2.39 | 2.09 |
| RONW | - | 19.2% | 24.3% | 32.5% | 17.2% | 18.1% | 14.3% | 60.2% | 27.3% | 45.3% | 25.9% | 23.0% | 15.8% | 14.4% |
| ROCE | 4.0% | 17.1% | 20.0% | 21.9% | 15.0% | 13.6% | 12.3% | 33.7% | 17.3% | 23.7% | 15.9% | 14.7% | 11.8% | 11.4% |